I wouldn’t expect much SP action from the initia

I wouldn’t expect much SP action from the initiation of this trial. CYDY has officially been an oncology company for a number of months and has shown great results in mTNBC and mBC. I think investors are waiting for the next step up, either BTD, good results from the basket trial, or continued good results from new and a larger number of patients in the mTNBC/mBC trial.